|
Volumn 18, Issue 6, 2009, Pages 527-529
|
Recontacting patients who have tested negative for BRCA1 and BRCA2 mutations: How, who and why?
|
Author keywords
BRCA1; BRCA2; Hereditary breast ovarian cancer syndrome; Risk notification
|
Indexed keywords
BRCA1 PROTEIN;
BRCA2 PROTEIN;
BREAST CANCER;
CANCER EPIDEMIOLOGY;
CANCER RISK;
CANCER SCREENING;
CANCER SUSCEPTIBILITY;
GENE MUTATION;
GENETIC COUNSELING;
HEALTH PROGRAM;
HUMAN;
NOTE;
BREAST NEOPLASMS;
DNA MUTATIONAL ANALYSIS;
FEMALE;
GENES, BRCA1;
GENES, BRCA2;
HUMANS;
OVARIAN NEOPLASMS;
PATIENT SELECTION;
POINT MUTATION;
|
EID: 70549083816
PISSN: 10597700
EISSN: 15733599
Source Type: Journal
DOI: 10.1007/s10897-009-9254-8 Document Type: Note |
Times cited : (13)
|
References (1)
|